Etica ID can create and operate your hospital's Antimicrobial Stewardship Program (ASP). Our team, made up of experienced infectious disease physicians, will partner with your hospital's pharmacists and leverage the data analysis capabilities of a third-party organization like the Duke Antimicrobial Stewardship Outreach Network (DASON) to optimize antibiotic use, combat resistance, improve patient outcomes, and reduce healthcare costs.

What We Offer:

• Tailored Program Design and Implementation: We design an ASP specific to your hospital's needs, embedding evidence-based guidelines into your daily practice.
• Expert Guidance: Our board-certified infectious disease specialists provide strategic direction, collaborating with your pharmacists to ensure antibiotic prescribing practices are both effective and responsible.
• Real-Time Monitoring and Feedback: We work with DASON’s data analysts to monitor antibiotic prescriptions, providing your team with real-time feedback for treatment optimization.
• Data-Driven Insights: Utilizing DASON's analytical prowess, we analyze your hospital's antimicrobial usage, infection rates, and resistance patterns, generating reports that drive quality improvements.
• Education and Training: We enhance your staff's expertise through educational programs, seminars, and tailored training sessions, ensuring ongoing education on antimicrobial stewardship best practices.
• Compliance and Accreditation Support: We assist in navigating regulatory requirements, such as those from The Joint Commission, to help your hospital excel in accreditation.
• Cost Reduction Strategies: By partnering with your pharmacists and utilizing DASON’s data, we strategize to cut unnecessary expenses, shorten hospital stays, and reduce adverse drug events.
• Patient Safety Initiatives: Our goal is to bolster patient safety by preventing the proliferation of resistant infections and promoting judicious antibiotic use.
• Site Visits: Bi-weekly site visits to inspect the facility for ASP process compliance and to meet with stakeholders to discuss the latest data.